ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis

INTRODUCTION: No clinically useful predictive factor has been yet identified for treatment of metastatic pancreatic cancer (mPC). It is noteworthy that FOLFIRINOX, despite its high toxicity, is effective only in some patients. We retrospectively analyzed expression of excision repair cross-complemen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Strippoli, Antonia, Rossi, Sabrina, Martini, Maurizio, Basso, Michele, D'Argento, Ettore, Schinzari, Giovanni, Barile, Rosalba, Cassano, Alessandra, Barone, Carlo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085217/
https://ncbi.nlm.nih.gov/pubmed/27147577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9063
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados